IL-6 Inhibition for Modulating Inflammation After Cardiac Arrest
Status:
Completed
Trial end date:
2020-06-30
Target enrollment:
Participant gender:
Summary
Resuscitated cardiac arrest is associated with a systemic inflammatory response that is
directly associated with poor prognosis. Inhibition of the IL-6 mediated immune response may
potentially inhibit the systemic inflammatory response, potentially improving the prognosis
of these severely ill patients.